tobramycin - medicine shortage information

Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Sort by: Updated date | Shortage status | Trade name

Product details	Supply Impact Dates	Further Details
TOBRAMYCIN WKT tobramycin 300mg/5mL solution for inhalation ampoules AUST R: 279353 Active ingredients: tobramycin Dosage form: Inhalation, conventional Sponsor: Arrotex Pharmaceuticals Pty Ltd Phone: 1800 195 055	From 24 Jul 2026 to 04 Sep 2026	Shortage status: Anticipated Availability: Available Reason: Unexpected increase in demand due to other sponsors unable to supply Management action: The sponsor is working to expedite the next shipment.
TOBI PODHALER tobramycin 28 mg hard capsule for inhalation blister pack with Podhaler device AUST R: 182302 Active ingredients: tobramycin Dosage form: Capsule, hard Sponsor: Viatris Pty Ltd Phone: 1800 314 527	From 01 May 2026 to 13 May 2026	Shortage status: Resolved Availability: Available Reason: Manufacturing
DBL TOBRAMYCIN tobramycin 80mg/2mL injection BP vial AUST R: 75686 Active ingredients: tobramycin Dosage form: Injection, solution Sponsor: Pfizer Australia Pty Ltd Phone: 1800-675-229	Deletion from market: 01 Apr 2026	Shortage status: Discontinued Availability: Reduction in supply until supply is exhausted Reason: Commercial Changes / Commercial viability Management action: An alternative generic product is available.
TOBI tobramycin 300mg/5mL solution for inhalation ampoule AUST R: 73172 Active ingredients: tobramycin Dosage form: Inhalation, conventional Sponsor: Viatris Pty Ltd Phone: 1800 314 527	Deletion from market: 30 Jan 2026	Shortage status: Discontinued Availability: Reduction in supply until supply is exhausted Reason: Commercial Changes / Commercial viability Management action: An alternative brand is available.
TOBRAMYCIN SUN tobramycin 300 mg/5 mL solution for inhalation ampoule AUST R: 285709 Active ingredients: tobramycin Dosage form: Inhalation, conventional Sponsor: Sun Pharma ANZ Pty Ltd Phone: 0298872600	Deletion from market: 01 May 2026	Shortage status: Discontinued Availability: Reduction in supply until supply is exhausted Reason: Manufacturing Management action: Alternative generic products are available.